Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.
The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Depressive Disorders market in Eastern Africa is experiencing significant growth and development.
Customer preferences: Customers in Eastern Africa are increasingly seeking treatment for depressive disorders due to a growing awareness and understanding of mental health issues. There is a rising demand for effective and accessible treatment options, including medication and therapy. Customers also prefer holistic approaches to treatment, incorporating lifestyle changes and alternative therapies such as yoga and meditation.
Trends in the market: One of the key trends in the Depressive Disorders market in Eastern Africa is the increasing availability and affordability of mental health services. Governments and healthcare providers are recognizing the importance of addressing mental health and are investing in the development of mental health infrastructure and services. This includes the establishment of specialized mental health clinics and the training of healthcare professionals in the diagnosis and treatment of depressive disorders. Another trend is the integration of technology in mental health services. The use of telemedicine and mobile health applications allows for remote consultations and monitoring of patients, improving access to care in remote areas. This trend is particularly relevant in Eastern Africa, where access to healthcare facilities can be limited in rural areas.
Local special circumstances: Eastern Africa faces unique challenges in addressing depressive disorders. Limited resources and infrastructure, as well as cultural stigma surrounding mental health, can hinder the delivery of effective treatment. However, there is a growing recognition of the need to overcome these barriers and provide comprehensive mental health services to the population.
Underlying macroeconomic factors: The economic growth and development in Eastern Africa have contributed to the increasing demand for mental health services. As the region experiences economic progress, there is a greater focus on overall well-being, including mental health. Additionally, the region has seen improvements in healthcare systems and increased investment in healthcare infrastructure, which has facilitated the growth of the Depressive Disorders market. In conclusion, the Depressive Disorders market in Eastern Africa is developing due to the increasing awareness and demand for mental health services. The market is characterized by customer preferences for holistic treatment options and the integration of technology in mental health services. Despite the challenges posed by limited resources and cultural stigma, the region is making progress in addressing depressive disorders. The underlying macroeconomic factors, including economic growth and improvements in healthcare infrastructure, are contributing to the market's development.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights